Considerations for developing an immunization strategy with enterovirus 71 vaccine

被引:34
作者
Li, Li [1 ]
Yin, Hongzhang [2 ]
An, Zhijie [1 ]
Feng, Zijian [1 ]
机构
[1] Chinese Ctr Dis Control & Prevent, Beijing 100050, Peoples R China
[2] China Food & Drug Adm, Ctr Drug Evaluat, Beijing 100050, Peoples R China
关键词
Enterovirus; 71; Hand; foot and mouth disease; Vaccine; Immunization strategy; MOUTH-DISEASE; DOUBLE-BLIND; FOOT; HAND; IMMUNOGENICITY; CHILDREN; SAFETY; EPIDEMIOLOGY; SEROEPIDEMIOLOGY; COXSACKIEVIRUS;
D O I
10.1016/j.vaccine.2014.10.081
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Enterovirus 71 (EV71) is a common pathogen for hand, foot, and mouth disease (HFMD), which has significant morbidity and mortality, and for which children aged 6-59 months age are at highest risk. Due to lack of effective treatment options, control of EV71 epidemics has mainly focused on development of EV71 vaccines. Clinical trials have been completed on 3 EV71 vaccines, with trial results demonstrating good vaccine efficacy and safety. When EV71 vaccine is approved by China's national regulatory authority, an evidence-based strategy should be developed to optimize impact and safety. An immunization strategy for EV71 vaccine should consider several factors, including the target population age group, the number of doses for primary immunization, the need for a booster dose, concomitant administration of other vaccines, economic value, program capacity and logistics, and public acceptance. Once EV71 vaccines are in use, vaccine effectiveness and safety must be monitored in large populations, and the epidemiology of HFMD must be evaluated to assure a match between vaccination strategy and epidemiology. Evaluation in China is especially important because there are no other EV71 vaccines globally. (C) 2015 Published by Elsevier Ltd.
引用
收藏
页码:1107 / 1112
页数:6
相关论文
共 35 条
[1]  
Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106
[2]   Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan [J].
Chang, LY ;
King, CC ;
Hsu, KH ;
Ning, HC ;
Tsao, KC ;
Li, CC ;
Huang, YC ;
Shih, SR ;
Chiou, ST ;
Chen, PY ;
Chang, HJ ;
Lin, TY .
PEDIATRICS, 2002, 109 (06) :e88
[3]   Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005 [J].
Chen, Kow-Tong ;
Chang, Hsiao-Ling ;
Wang, Shan-Tair ;
Cheng, Yan-Tzong ;
Yang, Jyh-Yuan .
PEDIATRICS, 2007, 120 (02) :E244-E252
[4]   Clinical evaluation for batch consistency of an inactivated enterovirus 71 vaccine in a large-scale phase 3 clinical trial [J].
Chen, Yi-Juan ;
Meng, Fan-Yue ;
Mao, Qun-Ying ;
Li, Jing-Xin ;
Wang, Hua ;
Liang, Zheng-Lun ;
Zhang, Yun-Tao ;
Gao, Fan ;
Chen, Qing-Hua ;
Hu, Yue-Mei ;
Ge, Zi-Jun ;
Yao, Xin ;
Guo, Hui-Jie ;
Zhu, Feng-Cai ;
Li, Xiu-Ling .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (05) :1366-1372
[5]   Formalin-Inactivated EV71 Vaccine Candidate Induced Cross-Neutralizing Antibody against Subgenotypes B1, B4, B5 and C4A in Adult Volunteers [J].
Chou, Ai-Hsiang ;
Liu, Chia-Chyi ;
Chang, Jui-Yuan ;
Jiang, Renee ;
Hsieh, Yi-Chin ;
Tsao, Amanda ;
Wu, Chien-Long ;
Huang, Ju-Lan ;
Fung, Chang-Phone ;
Hsieh, Szu-Min ;
Wang, Ya-Fang ;
Wang, Jen-Ren ;
Hu, Mei-Hua ;
Chiang, Jen-Ron ;
Su, Ih-Jen ;
Chong, Pele Choi-Sing .
PLOS ONE, 2013, 8 (11)
[6]  
Chua K B, 2007, Malays J Pathol, V29, P69
[7]  
Chua Kaw Bing, 2011, Virologica Sinica, V26, P221, DOI 10.1007/s12250-011-3195-8
[8]   Immunogenicity, Safety, and Lot Consistency of a Novel Inactivated Enterovirus 71 Vaccine in Chinese Children Aged 6 to 59 Months [J].
Hu, Yue-Mei ;
Wang, Xu ;
Wang, Jun-Zhi ;
Wang, Ling ;
Zhang, Yong-Jie ;
Chang, Lin ;
Liang, Zheng-Lun ;
Xia, Jie-Lai ;
Dai, Qi-Gang ;
Hu, Ya-Ling ;
Mao, Qun-Ying ;
Zhu, Feng-Cai ;
Song, Yu-Fei ;
Gao, Fan ;
Chen, Jiang-Ting .
CLINICAL AND VACCINE IMMUNOLOGY, 2013, 20 (12) :1805-1811
[9]   Forecasting the economic value of an Enterovirus 71 (EV71) vaccine [J].
Lee, Bruce Y. ;
Wateska, Angela R. ;
Bailey, Rachel R. ;
Tai, Julie H. Y. ;
Bacon, Kristina M. ;
Smith, Kenneth J. .
VACCINE, 2010, 28 (49) :7731-7736
[10]   An Inactivated Enterovirus 71 Vaccine in Healthy Children [J].
Li, Rongcheng ;
Liu, Longding ;
Mo, Zhaojun ;
Wang, Xuanyi ;
Xia, Jielai ;
Liang, Zhenglun ;
Zhang, Ying ;
Li, Yanping ;
Mao, Qunying ;
Wang, Jingjing ;
Jiang, Li ;
Dong, Chenghong ;
Che, Yanchun ;
Huang, Teng ;
Jiang, Zhiwei ;
Xie, Zhongping ;
Wang, Lichun ;
Liao, Yun ;
Liang, Yan ;
Nong, Yi ;
Liu, Jiansheng ;
Zhao, Hongling ;
Na, Ruixiong ;
Guo, Lei ;
Pu, Jing ;
Yang, Erxia ;
Sun, Le ;
Cui, Pingfang ;
Shi, Haijing ;
Wang, Junzhi ;
Li, Qihan .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (09) :829-837